Answers are grounded in this paper and cite their sources.
Clenbuterol, a long-acting selective beta-2 adrenoceptor agonist, is licensed as a bronchodilator in some countries but is increasingly misused for its lipolytic and anabolic effects.Acute overdose can produce significant sympathomimetic toxicity even in patients who appear well at initial presentation.A 35-year-old female presented to the emergency department approximately 2 hours after the deliberate ingestion of an estimated 30-40 tablets of clenbuterol 40 mcg (approximate total dose 1,200-1,600 mcg) as an act of impulsive self-harm.Despite a "well" general appearance and a Glasgow Coma Scale of 15, the patient had marked sinus tachycardia (heart rate 148 bpm) with a normal blood pressure (115/85 mmHg).Investigations demonstrated mild hypokalemia (potassium 3.3 mEq/L), mild hyperglycemia (glucose 6.8 mmol/L), and a markedly elevated lactate (6.49mmol/L); a venous blood gas showed no significant acidosis (pH 7.34, bicarbonate 24 mmol/L, anion gap 10 mmol/L), and the corrected QT interval was normal.In view of the large estimated dose, the short interval since ingestion, an intact airway, and medication packaging confirming the agent, gastric lavage was performed with recovery of tablet fragments, followed by 50 g of activated charcoal.The patient was admitted to the intensive care unit for continuous cardiac monitoring, serial electrolyte assessment, and supportive care.Tachycardia resolved spontaneously without betablockade (heart rate 82 bpm by 36 hours), electrolyte and metabolic abnormalities corrected, and the patient was discharged at 72 hours following psychiatric assessment and arrangement of outpatient follow-up.This case demonstrates that clenbuterol overdose may present with a deceptively benign appearance while producing significant tachycardia and metabolic derangement that can evolve over the ensuing 24-48 hours, consistent with the drug's prolonged half-life.Supportive care with continuous cardiac monitoring and careful electrolyte management is the mainstay of treatment; beta-blockade should be reserved for selected patients rather than used routinely, and gastric decontamination should be individualized.Psychiatric assessment and follow-up are essential following deliberate self-poisoning.
No takes yet. Share an insight, caveat, or question.
Kumar et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: